Pathogenesis of Alzheimer’s Disease by Agueda A. Rostagno

“…Alzheimer’s disease (AD) is the most common type of dementia, accounting for 60% to 80% of all cases [...]…”
Get full text

Prevention of Alzheimer's disease by V. A. Parfenov

Get full text

Epigenetics in Alzheimer’s Disease by Xiaodie Gao, Xiaodie Gao, Qiang Chen, Hua Yao, Jie Tan, Zheng Liu, Yan Zhou, Zhenyou Zou, Zhenyou Zou

Subjects: “…Alzheimer’s disease…”
Get full text

Alexithymia in Alzheimer’s Disease by Eva Mª Arroyo-Anlló, Corinne Souchaud, Pierre Ingrand, Jorge Chamorro Sánchez, Alejandra Melero Ventola, Roger Gil

Subjects: Get full text

Tienma and Alzheimer's disease by Huang, Junjie

Subjects: “…Alzheimer’s disease…”
Get full text
Get full text

Treatment for Alzheimer's disease. by Wilcock, G

Treating Alzheimer's disease. by Wilcock, G, Harrold, P

Neurotrophins in Alzheimer's disease by Wilcock, G

GENETICS OF ALZHEIMERS-DISEASE by Hardy, J, Goate, A, James, L, Irving, N, Mullan, M, Rossor, M, Giuffra, L

Galantamine in Alzheimer's disease. by Razay, G, Wilcock, G

“…Short-term, double-blind, placebo-controlled studies have shown that treatment with galantamine produces small improvements on cognitive tests and global measures of change in selected patients with mild to moderately severe Alzheimer's disease. A dose of 16-24 mg/day appears to be the most efficacious, and is the licensed maintenance dose range in most territories. …”

Velnacrine for Alzheimer's disease. by Birks, J, Wilcock, G

“… BACKGROUND: Alzheimer's disease (AD) is the commonest cause of dementia affecting older people. …”

Tacrine for Alzheimer's disease. by Qizilbash, N, Birks, J, López-Arrieta, J, Lewington, S, Szeto, S

“… BACKGROUND: Tacrine is one of the first drugs to be widely marketed for the loss of memory and intellectual decline in Alzheimer's disease. The alleged success of tacrine in the treatment of these symptoms has been heralded as confirmation of the cholinergic theory of Alzheimer's disease. …”

Age and Alzheimer's disease. by Wilcock, G, Esiri, M

Apathy in Alzheimer's disease by Nobis, L, Husain, M

“…Apathy is the most common neuropsychiatric symptom in patients with Alzheimer's disease (AD). The presence of apathy has been related to greater caregiver distress, decreased quality of life, and increased morbidity. …”

Neuropathology of Alzheimer's Disease by Gomez-Isla, T, Spires, T, De Calignon, A, Hyman, B

Hyperinsulinaemia and Alzheimer's disease. by Razay, G, Wilcock, G

“…Because the aetiology of Alzheimer's disease (AD) remains unclear, and fasting hyperinsulinaemia has been incriminated in several human diseases, we examined the relationship between AD, fasting plasma insulin, glucose, body mass index and waist: hip ratio in 24 men and 24 women aged 58-90 years of whom half had probable AD. …”

Autoantibodies in Alzheimer disease;. by Nilforooshan, R, Vincent, A, Eccles, J, Pettingill, R, Pettingill, P, Ali, L, Tabet, N

“…AIMS: There is increasing evidence to support the relevance of immune system in the pathogenesis of Alzheimer Disease (AD) and also there is growing evidence for importance of specific antibodies in some neurological disorders. …”

Pathologic diagnosis of Alzheimer's. by Köster, R, Esiri, M, Wilcock, G

Interventions in Alzheimer's disease. by Bucks, R, Byrne, L, Haworth, J, Wilcock, G, Hyde, J, Emmerson, C, Spaull, D

Smoking and Alzheimer's disease. by Peto, R